Edgewise Therapeutics Inc (EWTX) concluded trading on 01/11/24 at a closing price of $9.25, with 3.32 million shares of worth about $30.68 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 23.83% during that period and on Thursday the price saw a loss of about -16.74%. Currently the company’s common shares owned by public are about 63.26M shares, out of which, 36.03M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 13 times over the past 12 months. They bought 51,664 shares in 7 of the transactions. In 6 selling transactions, insiders dumped 13,039 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Edgewise Therapeutics Inc (NASDAQ: EWTX) started trading at $11.02, below -$0.09 from concluding price of the previous day. However, the stock later moved at a day high price of 11.92, or with a loss of -16.74%. Stock saw a price change of -9.14% in past 5 days and over the past one month there was a price change of 38.27%. Year-to-date (YTD), EWTX shares are showing a performance of -15.45% which increased to 2.55% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.12 but also hit the highest price of $12.46 during that period. The average intraday trading volume for Edgewise Therapeutics Inc shares is 481.74K. The stock is currently trading -2.94% below its 20-day simple moving average (SMA20), while that difference is up 20.94% for SMA50 and it goes to 23.18% higher than SMA200.
Edgewise Therapeutics Inc (NASDAQ: EWTX) currently have 63.26M outstanding shares and institutions hold larger chunk of about 65.58% of that.
The stock has a current market capitalization of $587.00M and its 3Y-monthly beta is at 0.10. It has posted earnings per share of -$1.41 in the same period. It has Quick Ratio of 18.23 while making debt-to-equity ratio of 0.02. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EWTX, volatility over the week remained 10.74% while standing at 9.95% over the month.
Stock’s fiscal year EPS is expected to drop by -22.05% while it is estimated to decrease by -33.36% in next year.
Analysts at 5 brokerage firms have issued recommendations for the Edgewise Therapeutics Inc (EWTX)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.00. Out of those 5 Wall Street analysts, 5 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
